☆ 4.3 Editorial Material

Rationale for IL-36 receptor antibodies in ulcerative colitis

EXPERT OPINION ON BIOLOGICAL THERAPY (2020)

Get Full Text
Add to Collection

Journal

EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 20, Issue 4, Pages 339-342

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/14712598.2020.1695775

Keywords

IL-36R; IL-36; ulcerative colitis; tissue remodeling

Categories

Biotechnology & Applied Microbiology Medicine, Research & Experimental

Funding

  1. DFG [SFB 1181-C02, TRR241-A08, TRR241-C02, FOR 2438, NE1927/2-2]
  2. German Research Council DFG

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.